Skip to main content

Randomized cross‐over trial comparing inpatient and outpatient administration of high‐dose cisplatin

Buy Article:

$43.00 plus tax (Refund Policy)

Background/Aims: Treatment with high‐dose cisplatin (HDC) previously required inpatient (IP) admission with overnight hospitalization, but recently practice has shifted to outpatient (OP) therapy. We aimed to determine whether it is preferable to give HDC as an IP or OP using a two‐period cross‐over trial.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: cisplatin; health services; inpatient; outpatient; patient preference

Document Type: Research Article

Affiliations: 1: Sydney Cancer Centre, Royal Prince Alfred Hospital 2: National Health and Medical Research Council Clinical Trials Centre, University of Sydney and

Publication date: 2011-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more